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High-output heart failureHigh-output heart failure is an uncommon type of acute heart
failure, and is caused by various pathological conditions, such as
anemia, sepsis, beriberi, congenital or acquired arteriovenous
ﬁstula, hyperthyroidism, psoriasis, and Paget disease of bone
[1,2]. The underlying pathophysiological condition in high-output
heart failure is reduced systemic vascular resistance, which is
elicited by either vasodilation of systemic resistant vessels or
systemic arteriovenous shunt. The decreased systemic vascular
resistance activates hemodynamic and neurohormonal responses
that maintain blood supply to the organs. The responses include an
increase in cardiac output [3] and the activation of the
sympathomimetic and renin–angiotensin–aldosterone systems
[4,5]. These neurohormonal alterations result in the retention of
sodium and water and an expansion of both extracellular ﬂuid and
plasma volume, which predispose the patients to the development
of congestive heart failure (Fig. 1).
Symptoms, physical ﬁndings, and laboratory tests in
high-output heart failure
Patients with high-output heart failure may complain of
typical symptoms of congestive heart failure including exertional
dyspnea, orthopnea, and peripheral edema. Physical examination
may reveal the dilatation of jugular veins, coarse crackles on lung
auscultation, a third sound on cardiac auscultation, and leg
edema, all of which are commonly found not only in patients with
high-output heart failure but also in those with much more
common low-output heart failure. However, the patients usually
show warm extremities suggesting that the extremities are well
perfused, which is sometimes a useful ﬁnding to notice the
existence of high-output state in patients with acute heart failure.
Patients with high-output heart failure may also have bounding
pulses and wide pulse pressure although these ﬁndings can beDOI of original article: http://dx.doi.org/10.1016/j.jccase.2015.01.004
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patent ductus arteriosus [6]. Echocardiography is essential to
assess chamber sizes, valvular function, and both systolic and
diastolic ventricular performances. Right heart catheterization
may be required in some cases to conﬁrm the existence of high-
output state in which cardiac output is high (e.g. more than
8 L/min) [1].
Causes of high-output heart failure and its treatment
Identifying the cause of symptomatic high-output heart failure
is vital to manage acute heart failure due to this condition, and
feasibility of the treatment depends on the underlying disease and
its severity. For example, in patients with refractory sepsis
and high-output heart failure, it may not be always easy to
manage this underlying disease of acute heart failure. It is also
important to be aware that underlying heart diseases play a pivotal
role in the development of symptomatic high-output heart failure
(Fig. 1). In other words, we have to search for an underlying heart
disease as soon as we notice the existence of high-output heart
failure [6]. According to the guidelines for the diagnosis and
management of heart failure in adults published by the American
Heart Association and American College of Cardiology, anemia
must be severe (e.g. hemoglobin levels less than 5 g/dl) to be the
sole cause of high-output heart failure [7].
In addition to the treatment of underlying diseases, such as
anemia, sepsis, beriberi, arteriovenous ﬁstulae, and hyperthy-
roidism, correction of excessive ﬂuid retention may also be useful
to manage symptomatic high-output heart failure. Dietary
restriction of sodium intake and judicious use of diuretics may
be helpful in some patients [1]. In the case of septic shock,
intravenous infusion of norepinephrine should be considered to
reverse the reduced systemic vascular resistance induced by
peripheral vasodilation [8]. There is a huge amount of evidence
supporting the use of angiotensin-converting enzyme inhibitors,
angiotensin receptor blockers, and beta-blockers in patients with
chronic heart failure and a low left ventricular ejection fraction
[7]. However, the administration of angiotensin-converting
enzyme inhibitors or angiotensin receptor blockers further
decreases systemic vascular resistance, and aggravates the
high-output state. Cautious use of a beta-blocker in combination
with an antithyroid drug may be beneﬁcial for some patients with
high-output heart failure due to hyperthyroidism when they have
sinus tachycardia or atrial ﬁbrillation with rapid ventricular
response [6].s reserved.
Fig. 1. Schematic diagram showing the mechanisms of the development of high-output failure.
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Imran et al. reported an interesting case of high-output heart
failure that was caused by a radiocephalic arteriovenous ﬁstula for
hemodialysis access with abnormally high shunt ﬂow [9]. The
patient presented with typical symptoms and signs of congestive
heart failure such as dyspnea, coarse crackles on auscultation, and
pitting edema of the lower extremities. Laboratory tests revealed a
high level of brain natriuretic peptide (5386 pg/ml) without an
increase in cardiac enzymes. Chest X-ray showed cardiomegaly
and pulmonary vascular congestion. It may not have been difﬁcult
to diagnose the patient as having acute exacerbation of congestive
heart failure, and the patient was successfully treated with
intravenous furosemide, bi-level positive airway pressure, and
the intravenous infusion of nitroglycerin. Since echocardiography
demonstrated severe aortic stenosis with a peak velocity of greater
than 4 m/s across the aortic valve, the authors scheduled aortic
valve replacement. The authors noticed the possibility of excessively
high shunt ﬂow at the arteriovenous ﬁstula for hemodialysis access
during physical examination, and ultrasound revealed an abnor-
mally high shunt-ﬂow volume of greater than 5 L/min, which
strongly suggested the existence of high-output state in the patient.
Finally, the patient underwent right heart catheterization, which
demonstrated an excessive cardiac output of 10.6 L/min and a
cardiac index of 5.2 L/min/m2. Before aortic valve replacement, the
patient was subjected to banding of the arteriovenous ﬁstula, which
reduced the shunt ﬂow to 1.8 L/min.
The importance of considering both an underlying heart
disease and shunt-ﬂow volume in patients with symptomatic
heart failure with an arteriovenous ﬁstula
Abnormally high shunt ﬂow at an arteriovenous ﬁstula for
hemodialysis access can cause high-output heart failure in patientswith end-stage renal disease, and several case reports have already
been published [10,11]. The excessively high shunt-ﬂow volume
can be reduced by banding, which mitigates the adverse effects of
systemic arteriovenous shunt on the hemodynamic condition
[12]. Even though the shunt ﬂow is appropriate, creation of an
arteriovenous ﬁstula elicits persistently high cardiac-output state
and increases myocardial oxygen demand, which may predispose
the patients with end-stage renal disease to a risk of myocardial
ischemia [13]. Therefore, patients with an underlying heart
disease, such as severe aortic stenosis as described in the case
report by Imran et al. [9] may be more likely to develop acute
exacerbation of heart failure after the creation of an arteriovenous
ﬁstula than those without a concomitant heart disease. In patients
with an underlying heart disease and abnormally high shunt-ﬂow
volume at the arteriovenous ﬁstula, the hemodynamic condition
may be easily aggravated.
In conclusion, the case reported by Imran et al. [9] highlighted
the importance of considering both an underlying heart disease
and shunt-ﬂow volume at the arteriovenous ﬁstula when we
treat patients with symptomatic heart failure who are on
hemodialysis.
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